DE68929096T2 - Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt - Google Patents
Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmtInfo
- Publication number
- DE68929096T2 DE68929096T2 DE68929096T DE68929096T DE68929096T2 DE 68929096 T2 DE68929096 T2 DE 68929096T2 DE 68929096 T DE68929096 T DE 68929096T DE 68929096 T DE68929096 T DE 68929096T DE 68929096 T2 DE68929096 T2 DE 68929096T2
- Authority
- DE
- Germany
- Prior art keywords
- receptor
- hrv
- human rhinovirus
- detergent
- receptor protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23957188A | 1988-09-01 | 1988-09-01 | |
US26242888A | 1988-10-25 | 1988-10-25 | |
US39066289A | 1989-08-10 | 1989-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68929096D1 DE68929096D1 (de) | 1999-12-16 |
DE68929096T2 true DE68929096T2 (de) | 2000-05-11 |
Family
ID=27399251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68929096T Expired - Lifetime DE68929096T2 (de) | 1988-09-01 | 1989-08-19 | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
Country Status (15)
Country | Link |
---|---|
US (1) | US7132395B1 (de) |
EP (1) | EP0362531B1 (de) |
JP (1) | JP3253064B2 (de) |
AT (1) | ATE186552T1 (de) |
AU (1) | AU637324B2 (de) |
CA (1) | CA1339193C (de) |
DE (1) | DE68929096T2 (de) |
DK (1) | DK174095B1 (de) |
ES (1) | ES2141076T3 (de) |
FI (1) | FI894065A (de) |
GR (1) | GR3032456T3 (de) |
IL (1) | IL91454A (de) |
NO (1) | NO893373L (de) |
NZ (1) | NZ230474A (de) |
PT (1) | PT91570B (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01502879A (ja) * | 1987-02-26 | 1989-10-05 | ダナ ファーバー キャンサー インスティテュート | Lfa―1のクローニング |
US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
US5151267A (en) * | 1988-07-15 | 1992-09-29 | University Of Saskatchewan | Bovine herpesvirus type 1 polypeptides and vaccines |
DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Ag | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
NO900155L (no) * | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
WO1990010652A1 (en) * | 1989-03-09 | 1990-09-20 | Dana Farber Cancer Institute | Method of treating viral infections using lfa-1 |
DK0391088T3 (da) * | 1989-03-16 | 1997-06-16 | Blood Res Center | Anvendelse af funktionelle derivater af det intercellulære adhæsionsmolekyle ICAM-1 til antiviral terapi |
WO1991018010A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
US5686581A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
DE69131564T2 (de) * | 1990-07-20 | 2000-01-13 | Bayer Ag | Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
US5686582A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
US5891841A (en) * | 1991-06-11 | 1999-04-06 | The Center For Blood Research, Inc. | Methods of using intercellular adhesion molecule-3 (ICAM-3), antibodies thereto, and soluble fragments thereof |
US6818743B1 (en) | 1992-01-27 | 2004-11-16 | Icos Corporation | I-CAM related protein |
US5525487A (en) * | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
US5989843A (en) * | 1992-01-27 | 1999-11-23 | Icos Corporation | Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein |
US6100383A (en) * | 1992-01-27 | 2000-08-08 | Icos Corporation | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions |
US6153395A (en) * | 1992-01-27 | 2000-11-28 | Icos Corporation | ICAM-related protein |
US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
US5880268A (en) * | 1992-01-27 | 1999-03-09 | Icos Corporation | Modulators of the interaction between ICAM-R and αd /CD18 |
US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
CA2107097A1 (en) * | 1992-01-27 | 1993-07-28 | Michael W. Gallatin | Icam-related protein |
AU710965B2 (en) * | 1992-06-22 | 1999-09-30 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
AU5466794A (en) * | 1992-11-18 | 1994-06-08 | Helsinki University Licensing Ltd Oy | Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
US5879712A (en) * | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
JP2000507221A (ja) * | 1996-03-06 | 2000-06-13 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 細胞間接着分子粉末組成物 |
US6391452B1 (en) | 1997-07-18 | 2002-05-21 | Bayer Corporation | Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
AU2004287875B2 (en) | 2003-11-05 | 2011-06-02 | Bausch + Lomb Ireland Limited | Modulators of cellular adhesion |
CN101175488B (zh) | 2005-05-17 | 2012-04-18 | 萨可德公司 | 治疗眼病的组合物和方法 |
JP5808037B2 (ja) | 2007-10-19 | 2015-11-10 | サーコード バイオサイエンス インク. | 糖尿病性網膜症の治療のための組成物及び方法 |
WO2009139817A2 (en) | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
CN110922393A (zh) | 2012-07-25 | 2020-03-27 | 诺华股份有限公司 | Lfa-1抑制剂及其多晶型物 |
AU2017224113B2 (en) | 2016-02-25 | 2022-04-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
US20170360815A1 (en) | 2016-02-25 | 2017-12-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261928A (en) | 1977-08-05 | 1981-04-14 | Sterling Drug Inc. | 2-Benzoyl-8-(2-chloro-4-methoxyphenoxy)-1-phenyl-1-octanone |
US4209526A (en) | 1977-08-05 | 1980-06-24 | Sterling Drug Inc. | Antiviral arylenedioxyalkyl substituted pyrazoles |
US4171365A (en) | 1977-08-05 | 1979-10-16 | Sterling Drug Inc. | Antiviral aryloxyalkylpyrazoles |
FR2432170A1 (fr) | 1978-06-12 | 1980-02-22 | Corning Glass Works | Procede de mesure de recepteurs d'antigene sur des membranes de cellules |
US4232161A (en) | 1979-10-24 | 1980-11-04 | Sterling Drug Inc. | 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-(2-pyridinyl)-1H-pyrazole |
US4234725A (en) | 1979-10-24 | 1980-11-18 | Sterling Drug Inc. | 4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-[4-(4-morpholinyl)-1-oxobutyl]-1H-pyrazole |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4427653A (en) | 1981-01-26 | 1984-01-24 | President And Fellows Of Harvard College | Method of making monoclonal antibodies |
US4372976A (en) | 1981-08-07 | 1983-02-08 | Sterling Drug Inc. | Novel aryl-aliphatic ketone and its use as an antiviral agent |
US4451476A (en) | 1982-12-13 | 1984-05-29 | Sterling Drug Inc. | Isoxazoles as antiviral agents |
US4843087A (en) | 1983-08-29 | 1989-06-27 | Sterling Drug Inc. | Di-heterocyclic compounds and their use as antiviral agents |
EP0169146A3 (de) * | 1984-07-20 | 1988-07-20 | Merck & Co. Inc. | Monoklonale Antikörper gegen den Rezeptor des menschlichen Rhinovirus |
JPS6181798A (ja) | 1984-07-23 | 1986-04-25 | ベクトン・デイツキンソン・アンド・カンパニ− | 細胞リセプタ−の回収 |
DE3505148A1 (de) | 1985-02-15 | 1986-10-30 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Polypeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele |
CA1280753C (en) | 1985-07-02 | 1991-02-26 | Philip Michael Carabateas | Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans |
EP0227604A3 (de) | 1985-12-23 | 1989-01-18 | Sandoz Ag | Verwendung von Oligopeptiden in der Behandlung von viralen Infektionen |
EP0261403A3 (de) | 1986-08-23 | 1988-04-13 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle |
DE3886237T2 (de) | 1987-02-26 | 1994-05-05 | Dana Farber Cancer Inst Inc | Reinigung von LFA-3. |
DE3712678A1 (de) | 1987-04-14 | 1988-10-27 | Boehringer Ingelheim Int | Rezeptor der kleinen rhinovirus rezeptor gruppe |
US5603932A (en) | 1987-04-14 | 1997-02-18 | Boehringer Ingelheim International Gmbh | Receptor of the minor human rhinovirus receptor group |
US5304636A (en) | 1987-04-14 | 1994-04-19 | Boehringer Ingelheim International Gmbh | Receptor for the human rhinovirus minor group |
AU629189B2 (en) | 1987-05-04 | 1992-10-01 | Dana-Farber Cancer Institute | Intercellular adhesion molecules and their binding ligands |
DE3854536T2 (de) | 1987-05-04 | 1996-03-07 | Dana Farber Cancer Inst Inc | Interzellulare Adhäsions-Moleküle und deren Bindungsliganden. |
US5284931A (en) | 1987-05-04 | 1994-02-08 | Dana Farber Cancer Institute | Intercellular adhesion molecules, and their binding ligands |
US5831036A (en) | 1987-05-04 | 1998-11-03 | Dana Farber Cancer Institute | Soluble fragments of human intercellular adhesion molecule-1 |
US4956281A (en) | 1987-06-03 | 1990-09-11 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3 |
US5109123A (en) | 1988-06-14 | 1992-04-28 | Dana Farber Cancer Institute | Alteration of ability of soluble CD4 fragments to bind HIV |
DE3852374T2 (de) | 1987-11-02 | 1995-05-04 | Baylor College Medicine | Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen. |
US5081228A (en) | 1988-02-25 | 1992-01-14 | Immunex Corporation | Interleukin-1 receptors |
CA1341055C (en) * | 1987-12-08 | 2000-07-18 | Alan Mcclelland | Transfectant cell lines which express the major human rhinovirus receptor |
US5395929A (en) | 1987-12-15 | 1995-03-07 | Dana Farber Cancer Institute | Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor |
EP0362526B1 (de) | 1988-08-23 | 1995-06-14 | Dana Farber Cancer Institute | Alpha-Subeinheit des LFA-1-Leukocyt-Adhäsions-Rezeptors |
DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Ag | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
US6143298A (en) | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
US6514936B1 (en) * | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
US6051231A (en) | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
ATE246245T1 (de) | 1988-09-28 | 2003-08-15 | Dana Farber Cancer Inst Inc | Interzellulare adhäsions-moleküle und deren bindungsliganden |
US5372933A (en) | 1988-10-03 | 1994-12-13 | The Scripps Research Institute | Polypeptides that mimic receptor-induced binding sites, and methods of using same |
NO900155L (no) | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
PT92900A (pt) | 1989-01-24 | 1990-07-31 | Sistema de vectores de expressao para a producao de anticorpos monoclonais quimericos | |
CA2008368C (en) | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
US5235049A (en) | 1989-01-24 | 1993-08-10 | Molecular Therapeutics, Inc. | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
EP0387701B1 (de) | 1989-03-09 | 1992-08-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Verwendung von interzellularen Adhäsions-Molekülen und deren Bindungsliganden bei der Behandlung von Asthma |
DK0391088T3 (da) | 1989-03-16 | 1997-06-16 | Blood Res Center | Anvendelse af funktionelle derivater af det intercellulære adhæsionsmolekyle ICAM-1 til antiviral terapi |
HU217792B (hu) | 1989-03-16 | 2000-04-28 | Dana Farber Cancer Institute | Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására |
US5324510A (en) | 1989-09-01 | 1994-06-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
US5349053A (en) | 1990-06-01 | 1994-09-20 | Protein Design Labs, Inc. | Chimeric ligand/immunoglobulin molecules and their uses |
EP0459577A3 (en) | 1990-06-01 | 1992-08-05 | Merck & Co. Inc. | Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
US5686582A (en) | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5686581A (en) | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US6107461A (en) | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
DE69131564T2 (de) | 1990-07-20 | 2000-01-13 | Bayer Ag | Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins |
US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
AU8631991A (en) | 1990-08-27 | 1992-03-17 | Cetus Corporation | Cd18 peptide medicaments for the treatment of disease |
US5288854A (en) | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
DE69123241T2 (de) | 1990-12-14 | 1997-04-17 | Cell Genesys Inc | Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen |
EP0510483A1 (de) | 1991-04-22 | 1992-10-28 | Boehringer Ingelheim Pharmaceuticals Inc. | Verfahren zum Nachweis von Viren |
US5223396A (en) | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
US5240694A (en) | 1991-09-23 | 1993-08-31 | University Of Virginia | Combined antiviral and antimediator treatment of common colds |
DE69229275T2 (de) | 1991-10-04 | 1999-12-30 | Us Health | Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen |
CA2107097A1 (en) | 1992-01-27 | 1993-07-28 | Michael W. Gallatin | Icam-related protein |
US5525487A (en) | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
US5532127A (en) | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
DE69328514T2 (de) | 1992-03-13 | 2001-01-11 | Monsanto Co | Herstellung rekombinanter Proteine unter Verwendung von Herpes-Virus-Promotoren und VP16-Transaktivatoren |
WO1994000485A1 (en) | 1992-06-22 | 1994-01-06 | Miles Inc. | Multimeric forms of human rhinovirus receptor protein |
US5580969A (en) | 1992-07-24 | 1996-12-03 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ICAM-I RNA |
US5879712A (en) | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
-
1989
- 1989-08-19 DE DE68929096T patent/DE68929096T2/de not_active Expired - Lifetime
- 1989-08-19 ES ES89115358T patent/ES2141076T3/es not_active Expired - Lifetime
- 1989-08-19 EP EP89115358A patent/EP0362531B1/de not_active Expired - Lifetime
- 1989-08-19 AT AT89115358T patent/ATE186552T1/de not_active IP Right Cessation
- 1989-08-22 NO NO89893373A patent/NO893373L/no unknown
- 1989-08-25 CA CA000609473A patent/CA1339193C/en not_active Expired - Fee Related
- 1989-08-25 AU AU40271/89A patent/AU637324B2/en not_active Ceased
- 1989-08-28 IL IL9145489A patent/IL91454A/en not_active IP Right Cessation
- 1989-08-29 NZ NZ230474A patent/NZ230474A/xx unknown
- 1989-08-30 PT PT91570A patent/PT91570B/pt not_active IP Right Cessation
- 1989-08-30 FI FI894065A patent/FI894065A/fi not_active Application Discontinuation
- 1989-08-31 DK DK198904312A patent/DK174095B1/da not_active IP Right Cessation
- 1989-09-01 JP JP22730189A patent/JP3253064B2/ja not_active Expired - Lifetime
-
1994
- 1994-09-30 US US08/316,384 patent/US7132395B1/en not_active Expired - Fee Related
-
2000
- 2000-01-25 GR GR20000400150T patent/GR3032456T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ230474A (en) | 1993-03-26 |
EP0362531B1 (de) | 1999-11-10 |
DK431289D0 (da) | 1989-08-31 |
JPH02238892A (ja) | 1990-09-21 |
FI894065A0 (fi) | 1989-08-30 |
JP3253064B2 (ja) | 2002-02-04 |
NO893373D0 (no) | 1989-08-22 |
FI894065A (fi) | 1990-03-02 |
PT91570B (pt) | 1995-05-31 |
CA1339193C (en) | 1997-08-05 |
AU4027189A (en) | 1990-03-08 |
EP0362531A1 (de) | 1990-04-11 |
PT91570A (pt) | 1990-03-30 |
US7132395B1 (en) | 2006-11-07 |
IL91454A (en) | 1995-08-31 |
ATE186552T1 (de) | 1999-11-15 |
AU637324B2 (en) | 1993-05-27 |
GR3032456T3 (en) | 2000-05-31 |
DK431289A (da) | 1990-03-02 |
DE68929096D1 (de) | 1999-12-16 |
DK174095B1 (da) | 2002-06-10 |
IL91454A0 (en) | 1990-04-29 |
ES2141076T3 (es) | 2000-03-16 |
NO893373L (no) | 1990-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929096T2 (de) | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt | |
UA41870C2 (uk) | Спосіб направлення клітинної відповіді на інфекційний агент, клітину, інфіковану вказаним агентом, пухлинну, злоякісну клітину або аутоімунну клітину (варіанти), клітина, яка експресує мембранозв'язаний білковий химерний рецептор (варіанти), днк,що кодує химерний рецептор, вектор, спосіб лікування інфекції вірусу імунодефіциту(варіанти) | |
DE68928069D1 (de) | Anti-T-Zell Rezeptordeterminanten zur Behandlung von Autoimmunkrankheiten | |
RU97115895A (ru) | Переключение клеточного иммунитета, осуществляемое с помощью тирозин-специфических протеинкиназных химер | |
DE69231223T2 (de) | Menschliche pf4a rezeptoren und ihre verwendung | |
ATE98376T1 (de) | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. | |
DE69232906T2 (de) | Detektion des Hepatis-C Virus. | |
DE3872754D1 (de) | Nachweis von antikoerpern humaner immundefizienz-viren. | |
ATE125870T1 (de) | Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. | |
OA09026A (en) | Method for detecting antibodies to human immunodeficiency virus. | |
FR2608767B1 (fr) | Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede | |
FR2655269B1 (fr) | Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv. | |
DE3889945T2 (de) | Methoden und Materialien für die HIV-Erkennung und Therapie. | |
EP0418347A4 (en) | Human monoclonal antibodies to human immunodeficiency virus | |
FR2629916B1 (fr) | Support solide pour diagnostic immunologique, son procede de traitement et application au diagnostic immunologique | |
Papamichail et al. | Binding of native and aggregated human γ-globulin by mouse lymphoid cells and fibroblasts | |
SU1540269A1 (ru) | Штамм гибридных культивируемых клеток животного mus musculus, используемый для получения моноклональных антител к поверхностному гликопротеину вирусов комплекса клещевого энцефалита | |
Kukaine et al. | Induction of bovine leukemia C-type oncornaviruses | |
KR880001806A (ko) | γ-인터페론의 제조방법과 그 용도 | |
Zhang et al. | AChR specific T lymphocytes in Myasthenia Gravis | |
SU1207004A1 (ru) | Способ прогнозирования эндомиометрита после операции кесарева сечения | |
RU95122100A (ru) | Способ иммунокоррекции носителя патогена | |
MW5888A1 (en) | Method for detecting antibodies to human immunodeficiency virus | |
SU1533329A1 (ru) | Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита | |
KR880010133A (ko) | Hiv 검출 및 치료를 위한 방법 및 물질 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |